Pediatric low-grade gliomas can be molecularly stratified for risk

Overview of attention for article published in Acta Neuropathologica, June 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 21,752 followers.

Pediatric low-grade gliomas can be molecularly stratified for risk. #NeuroPath https://t.co/CQlhs1onBJ

RT @NeuropathClinic: "Pediatric low-grade gliomas can be molecularly stratified for risk" https://t.co/rm41pd6S1y #Neuropath

RT @NeuropathClinic: "Pediatric low-grade gliomas can be molecularly stratified for risk" https://t.co/rm41pd6S1y #Neuropath

RT @NeuropathClinic: "Pediatric low-grade gliomas can be molecularly stratified for risk" https://t.co/rm41pd6S1y #Neuropath

RT @NeuropathClinic: "Pediatric low-grade gliomas can be molecularly stratified for risk" https://t.co/rm41pd6S1y #Neuropath

RT @NeuropathClinic: "Pediatric low-grade gliomas can be molecularly stratified for risk" https://t.co/rm41pd6S1y #Neuropath

RT @NeuropathClinic: "Pediatric low-grade gliomas can be molecularly stratified for risk" https://t.co/rm41pd6S1y #Neuropath

"Pediatric low-grade gliomas can be molecularly stratified for risk" https://t.co/rm41pd6S1y #Neuropath